// App-Quantinova.ai

: Characteristics Associated with Receipt of Immune Tolerance Induction Among Patients with Severe Hemophilia a in the United States in the Pre-Emicizumab Era

Researchers

Presenter

  • Christine L Kempton

Principal Investigators

  • Stacey Fedewa

  • Amanda B Payne

Medical Centers

  • Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Emory University, Atlanta, GA

  • Centers for Disease Control and Prevention, Atlanta, GA

  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved